Biotech Values

[DewDiligence]

QLTI acquires INSV in all-stock transaction:

http://finance.yahoo.com/news/insite-vision-merge-canadian-biotechnology-150200051.html

Shareholders of InSite Vision will receive 0.048 QLT shares for each InSite Vision share. For InSite Vision shareholders, the transaction represents a 27% premium based on the closing stock prices of InSite Vision and QLT as of June 5, 2015, the last trading day prior to the announcement of the merger. Upon completion of the merger, QLT shareholders will own approximately 89% and former InSite Vision shareholders will own approximately 11% of the combined company.

The nominal deal value (based on 6/5/8 closing prices) is $23.5M.

QLTI announced other financing and investment transactions today:
http://finance.yahoo.com/news/qlt-announces-multiple-transactions-designed-144900377.html

CC at 4:30pm ET.